Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3
- PMID: 8485919
- PMCID: PMC1554806
- DOI: 10.1111/j.1365-2249.1993.tb03402.x
Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3
Abstract
Murine MoAb 1-22-3 has already been reported to bind to the mesangial cell surface and to cause transient proteinuria and mesangial morphological changes characterized by mesangiolysis, subsequent mesangial cell proliferation and mesangial matrix increase by a single i.v. injection. In this study, MoAb-induced glomerulopathy was quantitatively analysed. No correlation between the severity of mesangial morphological changes and the degree of proteinuria was detected (r = 0.190). The minimum dose injected to induce abnormal proteinuria was 25 micrograms. This dose corresponded to 1.79 micrograms/2 kidneys 30 min after MoAb injection. The highest average level of proteinuria was observed in rats injected with 500 micrograms of MoAb, and less proteinuria was observed in rats injected with 10.0, 5.0 and 2.0 mg. Although the amounts of kidney-fixing MoAb and the subsequent deposition of rat C3 in the high-dose-injected group were larger than in the 500 micrograms injected group, the numbers of infiltrating inflammatory cells were the same in both groups. No correlations between the degrees of such mediators and proteinuria were observed.
Similar articles
-
Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen.Clin Exp Immunol. 1992 Jun;88(3):399-404. doi: 10.1111/j.1365-2249.1992.tb06461.x. Clin Exp Immunol. 1992. PMID: 1376651 Free PMC article.
-
Quantitative studies of monoclonal antibody 5-1-6-induced proteinuric state in rats.Clin Exp Immunol. 1992 Feb;87(2):215-9. doi: 10.1111/j.1365-2249.1992.tb02977.x. Clin Exp Immunol. 1992. PMID: 1735184 Free PMC article.
-
Divalency of the monoclonal antibody 5-1-6 is required for induction of proteinuria in rats.Clin Exp Immunol. 1993 Jun;92(3):522-6. doi: 10.1111/j.1365-2249.1993.tb03431.x. Clin Exp Immunol. 1993. PMID: 8513584 Free PMC article.
-
Mesangiolysis: an update.Am J Kidney Dis. 1998 Apr;31(4):559-73. doi: 10.1053/ajkd.1998.v31.pm9531171. Am J Kidney Dis. 1998. PMID: 9531171 Review.
-
Role of mesangial cell damage in progressive renal disease.Kidney Blood Press Res. 1999;22(1-2):5-12. doi: 10.1159/000025903. Kidney Blood Press Res. 1999. PMID: 10352402 Review.
Cited by
-
Progressive renal lesions induced by administration of monoclonal antibody 1-22-3 to unilaterally nephrectomized rats.Clin Exp Immunol. 1995 Oct;102(1):181-5. doi: 10.1111/j.1365-2249.1995.tb06653.x. Clin Exp Immunol. 1995. PMID: 7554387 Free PMC article.
-
Angiogenesis and chronic kidney disease.Fibrogenesis Tissue Repair. 2010 Aug 5;3:13. doi: 10.1186/1755-1536-3-13. Fibrogenesis Tissue Repair. 2010. PMID: 20687922 Free PMC article.
-
Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.Clin Exp Nephrol. 2005 Dec;9(4):271-281. doi: 10.1007/s10157-005-0388-1. Clin Exp Nephrol. 2005. PMID: 16362153 Review. No abstract available.
-
Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall.Am J Pathol. 2007 Jun;170(6):1841-53. doi: 10.2353/ajpath.2007.060484. Am J Pathol. 2007. PMID: 17525253 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous